Dose expansion results of the bifunctional EGFR/TGFb inhibitor BCA101 with pembrolizumab in patients with recurrent, metastatic head and neck squamous cell carcinoma Meeting Abstract
| Authors: | Hanna, G. J.; Kaczmar, J.; Zandberg, D. P.; Wong, D. J.; Yilmaz, E.; Sherman, E. J.; Calvo, A. H.; Sacco, A. G.; Bohr, D.; Reiners, R.; Bilic, S.; Salazar, R.; Gharakhani, E.; Chung, C. H. |
| Abstract Title: | Dose expansion results of the bifunctional EGFR/TGFb inhibitor BCA101 with pembrolizumab in patients with recurrent, metastatic head and neck squamous cell carcinoma |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-01-01 |
| Start Page: | S582 |
| End Page: | S583 |
| Language: | English |
| ACCESSION: | WOS:001087480201256 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.annonc.2023.09.2066 |
| Notes: | Meeting Abstract: 922P -- Source: Wos |
